TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
102,164
|
211,284
|
98,548 |
Earnings before taxes |
5,883
|
4,812
|
3,000 |
Total assets |
47,987
|
104,804
|
47,668 |
Current assets |
45,876
|
50,499
|
47,638 |
Current liabilities |
29,046
|
29,290
|
27,971 |
Equity capital |
18,729
|
65,777
|
19,295 |
- share capital |
537
|
538
![]() |
538 |
Employees (average) |
150
![]() |
150
![]() |
150 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.0%
|
62.8%
|
40.5% |
Turnover per employee |
681
|
1,409
|
657 |
Profit as a percentage of turnover |
5.8%
|
2.3%
|
3.0% |
Return on assets (ROA) | |||
Current ratio |
157.9%
|
172.4%
|
170.3% |
Return on equity (ROE) |
31.4%
|
7.3%
|
15.5% |
Change turnover |
-108,649
|
112,736
|
4,166 |
Change turnover % |
-52%
|
114%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.